Wells Fargo lowered the firm’s price target on DuPont to $75 from $85 and keeps an Overweight rating on the shares. The firm remains bullish on DuPont thanks to its strong balance sheet, stability in W&P, exposure to a recovery in China, and attractive valuation, with further upside from the acquisition of a high-quality healthcare name.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on DD:
- DuPont price target lowered to $81 from $85 at Mizuho
- DuPont price target lowered to $72 from $76 at Barclays
- DuPont Falls after Weak Outlook
- DuPont to acquire Spectrum Plastics Group from AEA Investors for $1.75B
- DuPont narrows FY23 adjusted EPS view to $3.55-$3.70 from $3.50-$4.00
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue